These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 31264073

  • 1. Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial.
    Quenot JP, Helms J, Bourredjem A, Dargent A, Meziani F, Badie J, Blasco G, Piton G, Capellier G, Mezher C, Rebibou JM, Nadji A, Crepin T, Barbar SD, Fleck C, Cransac A, Boulin M, Binquet C, Soudry-Faure A, Bruyère R, VERROU-REA Trial Investigators and the CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis).
    Ann Intensive Care; 2019 Jul 01; 9(1):75. PubMed ID: 31264073
    [Abstract] [Full Text] [Related]

  • 2. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
    Bruyère R, Soudry-Faure A, Capellier G, Binquet C, Nadji A, Torner S, Blasco G, Yannaraki M, Barbar SD, Quenot JP.
    Trials; 2014 Nov 19; 15():449. PubMed ID: 25409678
    [Abstract] [Full Text] [Related]

  • 3. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y, Li Z, Zhang L, Yang J, Yang Y, Tang Y, Fu P.
    Am J Kidney Dis; 2014 Mar 19; 63(3):479-90. PubMed ID: 24125729
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sodium citrate versus saline catheter locks for non-tunneled hemodialysis central venous catheters in critically ill adults: a randomized controlled trial.
    Hermite L, Quenot JP, Nadji A, Barbar SD, Charles PE, Hamet M, Jacquiot N, Ghiringhelli F, Freysz M.
    Intensive Care Med; 2012 Feb 19; 38(2):279-85. PubMed ID: 22124771
    [Abstract] [Full Text] [Related]

  • 6. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
    Kanaa M, Wright MJ, Akbani H, Laboi P, Bhandari S, Sandoe JA.
    Am J Kidney Dis; 2015 Dec 19; 66(6):1015-23. PubMed ID: 26141306
    [Abstract] [Full Text] [Related]

  • 7. Low Concentration Trisodium Citrate as a Non-inferior Locking Agent for Non-tunneled Dialysis Catheters in the Asian Setting.
    Jayaprakash V, Jagadeswaran D, Ezhilmathi K, Sathiapriya A, Vamsikrishna M, Indhumathi E, Jayakumar M.
    Indian J Nephrol; 2019 Dec 19; 29(6):410-414. PubMed ID: 31798223
    [Abstract] [Full Text] [Related]

  • 8. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Winnicki W, Herkner H, Lorenz M, Handisurya A, Kikić Ž, Bielesz B, Schairer B, Reiter T, Eskandary F, Sunder-Plassmann G, Sengoelge G.
    Kidney Int; 2018 Mar 19; 93(3):753-760. PubMed ID: 28890326
    [Abstract] [Full Text] [Related]

  • 9. Sodium bicarbonate is a potential alternative to classic heparin as a lock solution for non-tunneled dialysis catheters: a result from the prospective randomized BicarbLock trial.
    Islam M.
    Int Urol Nephrol; 2024 Apr 19; 56(4):1465-1474. PubMed ID: 37823971
    [Abstract] [Full Text] [Related]

  • 10. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.
    Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CE, Stas KJ, CITRATE Study Group.
    J Am Soc Nephrol; 2005 Sep 19; 16(9):2769-77. PubMed ID: 16033861
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomized controlled clinical trial of 4% sodium citrate versus heparin as locking solution for temporary dialysis catheters among hemodialysis patients
.
    Abdel Azim ABE, ElSaid TW, El Said HW, Hemida W, Zaghlool S, Ramadan A, Gouda Z, El Masry S, Reda W, Ali HM.
    Clin Nephrol; 2018 Nov 19; 90(5):341-349. PubMed ID: 30148449
    [Abstract] [Full Text] [Related]

  • 16. A Randomized Controlled Trial of Comparative Efficacy between Sodium Bicarbonate and Heparin as A Locking Solution for Tunneled Central Venous Catheters Among Patients Requiring Maintenance Hemodialysis.
    Wathanavasin W, Phannajit J, Poosoonthornsri M, Lewsuwan S, Tanateerapong P, Chongthanakorn K, Takkavatakarn K, Katavetin P, Tiranathanagul K, Eiam-Ong S, Susantitaphong P.
    Can J Kidney Health Dis; 2021 Nov 19; 8():20543581211046077. PubMed ID: 34616559
    [Abstract] [Full Text] [Related]

  • 17. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials.
    Mai H, Zhao Y, Salerno S, Li Y, Feng Y, Ma L, Fu P.
    Int Urol Nephrol; 2019 Jun 19; 51(6):1019-1033. PubMed ID: 31012037
    [Abstract] [Full Text] [Related]

  • 18. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
    Saxena AK, Panhotra BR.
    J Nephrol; 2005 Jun 19; 18(6):755-63. PubMed ID: 16358235
    [Abstract] [Full Text] [Related]

  • 19. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, Lynch K, Prout V, Cairns T, Griffith M, McLean A, Palmer A, Taube D.
    Am J Kidney Dis; 2009 Jun 19; 53(6):1034-41. PubMed ID: 19394731
    [Abstract] [Full Text] [Related]

  • 20. A 2% taurolidine catheter lock solution prevents catheter-related bloodstream infection (CRBSI) and catheter dysfunction in hemodialysis patients.
    Neusser MA, Bobe I, Hammermeister A, Wittmann U.
    Br J Nurs; 2021 Jul 22; 30(14):S24-S32. PubMed ID: 34288746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.